Jefferies Group's PFE Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 392,700 shares of Pfizer Inc. (PFE) worth $10.01 M, representing 0.05% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in PFE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 813,374 shares. Largest reduction occurred in Q1 2025, reducing 947,800 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +223,636 | New Buy | 223,636 | $51.24 |
| Q1 2023 | -155,733 | Reduce 69.64% | 67,903 | $40.80 |
| Q2 2023 | +36,528 | Add 53.79% | 104,431 | $36.68 |
| Q3 2023 | +15,815 | Add 15.14% | 120,246 | $33.17 |
| Q4 2023 | +150,214 | Add 124.92% | 270,460 | $28.79 |
| Q1 2024 | +194,545 | Add 71.93% | 465,005 | $27.75 |
| Q2 2024 | +746,856 | Add 160.61% | 1.21 M | $27.98 |
| Q3 2024 | -694,330 | Reduce 57.29% | 517,531 | $28.94 |
| Q4 2024 | +813,374 | Add 157.16% | 1.33 M | $26.53 |
| Q1 2025 | -947,800 | Reduce 71.21% | 383,105 | $25.34 |
| Q2 2025 | -129,721 | Reduce 33.86% | 253,384 | $24.24 |
| Q3 2025 | +139,316 | Add 54.98% | 392,700 | $25.48 |
Jefferies Group's Pfizer Investment FAQs
Jefferies Group first purchased Pfizer Inc. (PFE) in Q4 2022, acquiring 223,636 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Pfizer Inc. (PFE) for 12 quarters since Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to Pfizer Inc. (PFE) was in Q4 2024, adding 1,330,905 shares worth $35.31 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 392,700 shares of Pfizer Inc. (PFE), valued at approximately $10.01 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Pfizer Inc. (PFE) represents approximately 0.05% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in Pfizer Inc. (PFE) was 1,330,905 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.